“A Phase 2 Study of Oral Difelikefalin for Moderate-to-Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)” (2022) SKIN The Journal of Cutaneous Medicine, 6(6), p. s104. doi:10.25251/skin.6.supp.104.